| EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract M Dottori, L Hartley, M Galea, G Paxinos, M Polizzotto, T Kilpatrick, ... Proceedings of the National Academy of Sciences 95 (22), 13248-13253, 1998 | 377 | 1998 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 376 | 2021 |
| Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: prospective characterization of KSHV inflammatory … MN Polizzotto, TS Uldrick, KM Wyvill, K Aleman, V Marshall, V Wang, ... Clinical Infectious Diseases 62 (6), 730-738, 2016 | 243 | 2016 |
| Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome MN Polizzotto, TS Uldrick, D Hu, R Yarchoan Frontiers in microbiology 3, 73, 2012 | 242 | 2012 |
| Castleman disease A Carbone, M Borok, B Damania, A Gloghini, MN Polizzotto, ... Nature Reviews Disease Primers 7 (1), 84, 2021 | 219 | 2021 |
| Kaposi sarcoma–associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment M Bhutani, MN Polizzotto, TS Uldrick, R Yarchoan Seminars in oncology 42 (2), 223-246, 2015 | 195 | 2015 |
| Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease MN Polizzotto, TS Uldrick, V Wang, K Aleman, KM Wyvill, V Marshall, ... Blood, The Journal of the American Society of Hematology 122 (26), 4189-4198, 2013 | 194 | 2013 |
| High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy TS Uldrick, MN Polizzotto, K Aleman, D O'Mahony, KM Wyvill, V Wang, ... Blood, The Journal of the American Society of Hematology 117 (26), 6977-6986, 2011 | 175 | 2011 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 154 | 2022 |
| Bisphosphonate‐associated osteonecrosis of the auditory canal MN Polizzotto, V Cousins, AP Schwarer British journal of haematology 132 (1), 114-114, 2006 | 149 | 2006 |
| Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease TS Uldrick, MN Polizzotto, K Aleman, KM Wyvill, V Marshall, D Whitby, ... Blood, The Journal of the American Society of Hematology 124 (24), 3544-3552, 2014 | 146 | 2014 |
| Viral, immunologic, and clinical features of primary effusion lymphoma K Lurain, MN Polizzotto, K Aleman, M Bhutani, KM Wyvill, PH Gonçalves, ... Blood, The Journal of the American Society of Hematology 133 (16), 1753-1761, 2019 | 145 | 2019 |
| Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial RT Davey, E Fernández-Cruz, N Markowitz, S Pett, AG Babiker, ... The Lancet Respiratory Medicine 7 (11), 951-963, 2019 | 142 | 2019 |
| Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy TS Uldrick, KM Wyvill, P Kumar, D O'Mahony, W Bernstein, K Aleman, ... Journal of clinical oncology 30 (13), 1476-1483, 2012 | 138 | 2012 |
| Pomalidomide for symptomatic Kaposi's sarcoma in people with and without HIV infection: a phase I/II study MN Polizzotto, TS Uldrick, KM Wyvill, K Aleman, CJ Peer, M Bevans, ... Journal of Clinical Oncology 34 (34), 4125-4131, 2016 | 136 | 2016 |
| Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling P Gasperini, G Espigol-Frigole, PJ McCormick, O Salvucci, D Maric, ... Cancer research 72 (5), 1157-1169, 2012 | 129 | 2012 |
| Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease TS Uldrick, MN Polizzotto, R Yarchoan Current opinion in oncology 24 (5), 495-505, 2012 | 110 | 2012 |
| Expression of “suppressor of cytokine signalling”(SOCS) genes in the developing and adult mouse nervous system MN Polizzotto, PF Bartlett, AM Turnley Journal of Comparative Neurology 423 (2), 348-358, 2000 | 110 | 2000 |
| Fluid skills: Drinking games and alcohol consumption among Australian university students MN Polizzotto, MM Saw, I Tjhung, EH Chua, TR Stockwell Drug and Alcohol Review 26 (5), 469-475, 2007 | 109 | 2007 |
| HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults NJ Dharan, P Yeh, M Bloch, MM Yeung, D Baker, J Guinto, N Roth, ... Nature medicine 27 (6), 1006-1011, 2021 | 100 | 2021 |
Thomas S UldrickMedical Director, Regeneron; Associate Member, Fred Hutchinson Cancer InstituteVerified email at fredhutch.org
